Front page

Cyber risk, the need for proprietary data and the rush to finance AI are top of mind for Carlyle Group CEO Harvey Schwartz.

Industrials, defence and healthcare sectors stand to benefit, co-head of Americas PE Steve Wise tells PEI.

GPs including Bain and Apollo said at the UK Private Capital Summit that it is difficult to quantify claims around AI's contribution to value creation and cost reduction.

Disclosed healthcare buyout value fell to $51bn in H1 2026 from around $60bn a year earlier, with pressures from AI disruption and the Iran war contributing to the slowdown.

As deploying capital gets harder, lenders and lawyers are turning to hybrid structures that blend sub-line mechanics with parallel vehicles and squeezing more leverage out of uncalled commitments.

The pressing need for more healthcare professionals globally is proving a tailwind for PE investors in medical education.

The private equity model isn’t broken, but the illusion of uniform success is, writes Scott Hart, partner and chief executive at StepStone Group.

The combination of the two firms, which will create the world's largest healthcare private equity investor, will change how healthcare investing is done by linking East and West opportunities, its co-chief executives tell PEI.

Documents prepared for an LP investment committee meeting reveal details of the GP stakes giant's approach to generating liquidity.

The number of Asia-Pacific portfolio companies held for more than five years rose 18% in 2025, according to Bain & Co’s Asia-Pacific Private Equity Report 2026.